Gall Bladder Cancer Clinical Trials

11 recruitingLast updated: June 17, 2026

There are 11 actively recruiting gall bladder cancer clinical trials across 12 countries. Studies span Phase 2, Phase 1, Not Applicable, Phase 3. Top locations include Mumbai, Maharashtra, India, Philadelphia, Pennsylvania, United States, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Gall Bladder Cancer Trials at a Glance

11 actively recruiting trials for gall bladder cancer are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Mumbai, Philadelphia, and Dallas. Lead sponsors running gall bladder cancer studies include Tata Memorial Centre, Karolinska University Hospital, and First Affiliated Hospital of Zhejiang University.

Browse gall bladder cancer trials by phase

Treatments under study

About Gall Bladder Cancer Clinical Trials

Looking for clinical trials for Gall Bladder Cancer? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gall Bladder Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gall Bladder Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 1Phase 2

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Breast CancerOvarian CancerProstate Cancer+6 more
University of Florida29 enrolled1 locationNCT05000294
Recruiting

DESTINY-PANTUMOUR04

Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled17 locationsNCT07124000
Recruiting
Phase 1

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)Gastric Cancer (GC)+1 more
Shenzhen Xinhe Biomedical48 enrolled2 locationsNCT07594964
Recruiting
Phase 1Phase 2

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Breast CancerTriple-Negative Breast CancerColorectal, Cancer+26 more
PMV Pharmaceuticals, Inc300 enrolled76 locationsNCT04585750
Recruiting

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre60 enrolled1 locationNCT07337850
Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

ctDNAGall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)+3 more
Yingbin Liu, MD, PhD, FACS1,800 enrolled1 locationNCT07176962
Recruiting
Not Applicable

Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)

Gall Bladder Cancer
Karolinska University Hospital94 enrolled1 locationNCT06246448
Recruiting
Phase 2

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
First Affiliated Hospital of Zhejiang University60 enrolled1 locationNCT07025174
Recruiting
Phase 2Phase 3

Radiation Therapy in Unresectable Gall Bladder Cancer

Gall Bladder Cancer
Tata Memorial Centre249 enrolled1 locationNCT06214572
Recruiting
Phase 2

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital33 enrolled1 locationNCT06852287
Recruiting
Not Applicable

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Colorectal, CancerEsophageal CancerGastric Cancer+8 more
University of California, Davis300 enrolled1 locationNCT06101277